Could a genetic biomarker predict your risk for severe food allergies?

Researchers at Ann & Robert H. Lurie Children’s Hospital of Chicago have identified a genetic biomarker, α-tryptase, that may predict the severity of food allergy reactions. This discovery opens the door for new treatment strategies and offers a way to distinguish patients at risk for severe reactions.

Protein profiling reveals impact of aging and resistance training on skeletal muscle proteome

A new research paper was published in Aging (listed by MEDLINE/PubMed as “Aging (Albany NY)” and “Aging-US” by Web of Science) Volume 16, Issue 8,

May 2, 2024

Late-stage results set up Cytokinetics heart drug to compete with Bristol

Late-stage results of Cytokinetics’ drug for a rare heart disease suggest it can compete with a similar treatment sold by Bristol Myers Squibb on efficacy

May 13, 2024

Morning Rounds: Americans put faith in nurses as overall confidence in health care ebbs

Understand how science, health policy, and medicine shape the world everyday. Sign up for our Morning Rounds newsletter here. Good morning. Today we take a look

December 20, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.